A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032).

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Saif, A; Verbus, EA; Sarvestani, AL; Teke, ME; Lambdin, J; Hernandez, JM; Kirsch, DG

Published Date

  • February 2023

Published In

Volume / Issue

  • 30 / 2

Start / End Page

  • 683 - 685

PubMed ID

  • 36396869

Electronic International Standard Serial Number (EISSN)

  • 1534-4681

Digital Object Identifier (DOI)

  • 10.1245/s10434-022-12762-z

Language

  • eng

Conference Location

  • United States